Consolidated statement of changes in shareholders’ equity
CHF million | Retained earnings | |||||||||||||
Share | Capital | Treasury | Hedging | Revaluation | Other | Total | ||||||||
As at 31 December 2017 | 797.1 | 49.4 | –4.9 | –25.1 | 214.2 | 1 120.0 | 2 150.7 | |||||||
First application IFRS 15 | 1.5 | 1.5 | ||||||||||||
Net profit | 161.0 | 161.0 | ||||||||||||
Valuation of financial instruments | 9.4 | 9.4 | ||||||||||||
Changes in employee benefits | –0.2 | –0.2 | ||||||||||||
Total comprehensive income | 9.4 | 160.8 | 170.2 | |||||||||||
Purchase treasury shares | –36.1 | –36.1 | ||||||||||||
Sale treasury shares | 31.9 | –0.3 | 31.6 | |||||||||||
Nominal value reduction | –781.2 | 781.2 | 0.0 | |||||||||||
Distribution to shareholders | –99.3 | –99.3 | ||||||||||||
Share-based reimbursement | 0.2 | 0.2 | ||||||||||||
Reclassification | 45.3 | –45.3 | 0.0 | |||||||||||
As at 31 December 2018 | 15.9 | 731.3 | –8.9 | –15.7 | 259.5 | 1 236.7 | 2 218.8 | |||||||
Net profit | 234.8 | 234.8 | ||||||||||||
Valuation of financial instruments | 7.0 | 7.0 | ||||||||||||
Changes in employee benefits | 9.1 | 9.1 | ||||||||||||
Total comprehensive income | 7.0 | 243.9 | 250.9 | |||||||||||
Purchase treasury shares | 0.0 | 0.0 | ||||||||||||
Sale treasury shares | 1.6 | 0.3 | 1.9 | |||||||||||
Distribution to shareholders | –103.3 | –103.3 | ||||||||||||
Share-based reimbursement | 0.2 | 0.2 | ||||||||||||
Reclassification | 100.2 | –100.2 | 0.0 | |||||||||||
As at 31 December 2019 | 15.9 | 628.0 | –7.1 | –8.7 | 359.7 | 1 380.7 | 2 368.5 |
Capital reserves represent the amount (premium) earned by shareholders over and above the nominal value on
subscription of share capital of Allreal Holding AG after deduction of the corresponding issue costs.